To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Clinical outcomes, molecular epidemiology and resistance mechanisms of multi-drug resistant Pseudomonas aeruginosa isolated from blood stream infections from Qatar
Örebro University, School of Science and Technology. Division of Microbiology, Department of Pathology and Laboratory Medicine, Hamad Medical Corporation, Doha, Qatar. (The Life Science Centre-Biology)ORCID iD: 0000-0002-6186-7770
Division of Microbiology, Department of Pathology and Laboratory Medicine, Hamad Medical Corporation, Doha, Qatar.
Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
Show others and affiliations
(English)Manuscript (preprint) (Other academic)
National Category
Other Biological Topics
Identifiers
URN: urn:nbn:se:oru:diva-87550OAI: oai:DiVA.org:oru-87550DiVA, id: diva2:1503366
Available from: 2020-11-24 Created: 2020-11-24 Last updated: 2020-11-24Bibliographically approved
In thesis
1. Molecular Epidemiology and Mechanisms of Antibiotic Resistance in Clinical Isolates of Pseudomonas aeruginosa from Qatar
Open this publication in new window or tab >>Molecular Epidemiology and Mechanisms of Antibiotic Resistance in Clinical Isolates of Pseudomonas aeruginosa from Qatar
2020 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Inappropriate and excessive use of antibiotics promotes antimicrobial resistance (AMR), particularly in Gram-negative bacteria (GNB). There is a noticeable increase in nosocomial infections caused by multidrug-resistant (MDR) Pseudomonas aeruginosa, which is associated with significant morbidity, mortality, and an increase in cost management. Although this is a global problem, there is a lack of sufficient data on regional differences that can contribute towards effective AMR management. This thesis presents a study of MDR-P. aeruginosa at five different hospitals in Qatar conducted prospectively between October 2014 - September 2017. The aim was to study the epidemiology, microbiological and clinical characteristics of MDR-P. aeruginosa infections as well as investigate the activity of new antibiotic combinations against these bacteria. The prevalence of MDR-P. aeruginosa isolates in the first year was 8.1% (205/2533), isolated from different clinical specimens, but the majority were from respiratory infections (44.9%, n=92). Most cases were exposed to antibiotics during the 90 days prior to isolation (85.4%, n=177), and the resistance to cefepime, ciprofloxacin, piperacillin/tazobactam, meropenem was >90%. To compare pre- and post-Antimicrobial Stewardship Program, there was a significant reduction in antibiotic consumption by 30.4% of total inpatient antibiotic prescriptions (p=0.008) and the prevalence of MDR-P. aeruginosa significantly declined from 9% to 5.4% (p=0.019). The in vitro investigation of ceftazidime/avibactam (CZA) and ceftolozane/tazobactam (C/T) against MDR-P. aeruginosa isolates, showed promising results with susceptibility of 68.8% (n=141/205) and 62.9% (n=129/205), respectively, which was higher than other antipseudomonal agents except colistin. Seventy-five isolates that were sequenced belonged to 29 different sequence types, with ST235 being predominant at 21.3% (16/75). Among the 42 isolates that were resistant to CZA and/or C/T, the most prevalent genes were blaOXA-488 and blaVEB-9 detected in 45.2% (19/42) of isolates. Spearman’s analysis showed that resistance to CZA and C/T were positively correlated with the presence of blaOXA-10, blaPDC-2a, blaVIM-2, and blaVEB-9 , respectively. The study highlights potential key mechanisms that could explain the resistance of MDR-P. aeruginosa to the new antibiotic combinations.

Place, publisher, year, edition, pages
Örebro: Örebro University, 2020. p. 92
Series
Örebro Studies in Life Science, ISSN 1653-3100 ; 17
Keywords
Antibiotics, C/T, CZA, MDR, Pseudomonas aeruginosa, ST235, VEB, VIM
National Category
Other Biological Topics
Identifiers
urn:nbn:se:oru:diva-85159 (URN)978-91-7529-353-0 (ISBN)
Public defence
2020-12-16, Örebro universitet, Långhuset, Hörsal L2, Fakultetsgatan 1, Örebro, 13:15 (English)
Opponent
Supervisors
Note

I den fysiska versionen av avhandlingen är den angivna tidpunkten för avhandlingen 21 oktober, 2020, 13:00 med plats Hörsal F, Forumhuset, Örebro universitet. Disputationen blev dock inställd och fick nytt datum och plats (dessa anges ovan).

Available from: 2020-08-26 Created: 2020-08-26 Last updated: 2023-01-26Bibliographically approved

Open Access in DiVA

No full text in DiVA

Authority records

Sid Ahmed, MazenJass, Jana

Search in DiVA

By author/editor
Sid Ahmed, MazenJass, Jana
By organisation
School of Science and Technology
Other Biological Topics

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 206 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf